The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Townsend Richard Nolan since 2024.
This trader's CIK number is 1995218.
At the time of last reporting, Townsend Richard Nolan was the Chief Executive Officer of Lexeo Therapeutics, Inc.. (stock ticker symbol LXEO).
Also see all insider trading activities at Lexeo Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | LXEO | 0 | $0 | 8,135 | $34,835 | 0 | $0 |
| 2024 | LXEO | 0 | $0 | 85,000 | $1,301,495 | 35,000 | $81,550 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-18 | LXEO | Sale | 2,735 | 4.67 | 12,766 |
| 2025-05-16 | LXEO | Sale | 1,074 | 2.77 | 2,979 |
| 2025-02-19 | LXEO | Sale | 4,326 | 4.41 | 19,090 |
| 2024-12-10 | LXEO | Option Ex | 2,500 | 2.33 | 5,825 |
| 2024-12-10 | LXEO | Sale | 2,500 | 8.20 | 20,492 |
| 2024-11-11 | LXEO | Option Ex | 2,500 | 2.33 | 5,825 |
| 2024-11-11 | LXEO | Sale | 2,500 | 7.82 | 19,557 |
| 2024-10-10 | LXEO | Option Ex | 5,000 | 2.33 | 11,650 |
| 2024-10-10 | LXEO | Sale | 5,000 | 8.10 | 40,495 |
| 2024-09-10 | LXEO | Option Ex | 5,000 | 2.33 | 11,650 |
| 2024-09-10 | LXEO | Sale | 5,000 | 10.65 | 53,275 |
| 2024-08-12 | LXEO | Option Ex | 5,000 | 2.33 | 11,650 |
| 2024-08-12 | LXEO | Sale | 5,000 | 11.53 | 57,634 |
| 2024-07-11 | LXEO | Sale | 28,031 | 18.06 | 506,239 |
| 2024-07-10 | LXEO | Sale | 26,969 | 16.65 | 449,033 |
| 2024-07-10 | LXEO | Option Ex | 5,000 | 2.33 | 11,650 |
| 2024-06-10 | LXEO | Option Ex | 5,000 | 2.33 | 11,650 |
| 2024-06-10 | LXEO | Sale | 5,000 | 17.73 | 88,675 |
| 2024-05-13 | LXEO | Option Ex | 5,000 | 2.33 | 11,650 |
| 2024-05-13 | LXEO | Sale | 5,000 | 13.22 | 66,095 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Townsend Richard Nolan (Chief Executive Officer of Lexeo Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.